- Report
- November 2023
- 174 Pages
Global
From €5223EUR$5,950USD£4,544GBP
- Report
- September 2025
- 85 Pages
Malaysia
From €3072EUR$3,500USD£2,673GBP
- Report
- December 2024
- 88 Pages
Egypt
From €3072EUR$3,500USD£2,673GBP
- Report
- November 2024
- 183 Pages
Global
From €3950EUR$4,500USD£3,437GBP
- Report
- April 2024
- 85 Pages
India
From €3072EUR$3,500USD£2,673GBP
From €3072EUR$3,500USD£2,673GBP
From €3072EUR$3,500USD£2,673GBP
- Report
- October 2023
- 90 Pages
Israel
From €3072EUR$3,500USD£2,673GBP
- Report
- October 2023
- 89 Pages
Malaysia
From €3072EUR$3,500USD£2,673GBP
- Report
- October 2023
- 79 Pages
Malaysia
From €3072EUR$3,500USD£2,673GBP
- Report
- August 2023
- 79 Pages
Canada
From €3072EUR$3,500USD£2,673GBP
- Report
- August 2023
- 78 Pages
Israel
From €3072EUR$3,500USD£2,673GBP
- Report
- August 2023
- 77 Pages
Canada
From €3072EUR$3,500USD£2,673GBP
- Report
- August 2023
- 76 Pages
Egypt
From €3072EUR$3,500USD£2,673GBP
- Report
- January 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- December 2024
- 175 Pages
Global
From €4389EUR$5,000USD£3,818GBP
- Report
- March 2024
- 200 Pages
Global
From €3643EUR$4,150USD£3,169GBP
- Report
- March 2024
- 200 Pages
Global
From €3643EUR$4,150USD£3,169GBP
- Report
- March 2024
- 200 Pages
Global
From €3643EUR$4,150USD£3,169GBP
- Report
- July 2024
- 150 Pages
Global
From €3292EUR$3,750USD£2,864GBP

The Defibrillator market is a segment of the Cardiovascular Devices industry. Defibrillators are medical devices used to restore normal heart rhythm in patients suffering from cardiac arrhythmias. These devices are used in both in-hospital and out-of-hospital settings, and are typically used in emergency situations. Defibrillators can be divided into two main categories: implantable and external. Implantable defibrillators are surgically implanted into the patient's chest, while external defibrillators are used externally and are typically used in emergency situations.
Defibrillators are used to treat a variety of cardiac conditions, including ventricular fibrillation, ventricular tachycardia, and atrial fibrillation. The market for defibrillators is expected to grow due to the increasing prevalence of cardiovascular diseases, technological advancements, and the increasing demand for home-based defibrillators.
Some of the major companies in the Defibrillator market include Medtronic, St. Jude Medical, Biotronik, Boston Scientific, and Philips Healthcare. Show Less Read more